Cover
Cover | Jun. 26, 2023 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Current Report on Form 8-K/A (this "Amendment") amends the Current Report on Form 8-K filed by United Therapeutics Corporation (the "Company") with the U.S. Securities and Exchange Commission on June 28, 2023 (the "Original Form 8-K"). |
Document Period End Date | Jun. 26, 2023 |
Entity File Number | 000-26301 |
Entity Registrant Name | United Therapeutics Corporation |
Entity Central Index Key | 0001082554 |
Entity Tax Identification Number | 52-1984749 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 1000 Spring Street |
Entity Address, City or Town | Silver Spring |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20910 |
City Area Code | 301 |
Local Phone Number | 608-9292 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
Trading Symbol | UTHR |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |